Want to join the conversation?
James Schneider from Goldman Sachs asks about the overall headcount plans for the remainder of the year. $CTSH said utilization came down a little bit in 1Q16, which was intentional. Headcount additions will slow in 2H16 from 1H16, but the goal will be to keep utilization in the ballpark that it is currently at.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)